Kesler Norman & Wride’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
14,375
-67
-0.5% -$5.41K 0.18% 133
2026
Q1
$1.25M Buy
14,442
+165
+1% +$15.8K 0.22% 107
2025
Q4
$1.37M Sell
14,277
-42,554
-75% -$4.13M 0.24% 99
2025
Q3
$4.54M Buy
56,831
+43,410
+323% +$3.99M 0.89% 42
2025
Q2
$1.17M Sell
13,421
-45,099
-77% -$3.82M 0.21% 104
2025
Q1
$5.26M Buy
58,520
+1,689
+3% +$151K 1% 36
2024
Q4
$4.54M Sell
56,831
-2,157
-4% -$187K 0.98% 38
2024
Q3
$5.31M Buy
58,988
+220
+0.4% +$18.5K 1.04% 37
2024
Q2
$4.63M Sell
58,768
-1,567
-3% -$128K 0.98% 39
2024
Q1
$5.26M Buy
60,335
+1,174
+2% +$100K 1.12% 34
2023
Q4
$4.87M Buy
59,161
+872
+1% +$66.5K 1.12% 35
2023
Q3
$4.57M Buy
58,289
+2,705
+5% +$226K 1.15% 31
2023
Q2
$4.9M Buy
55,584
+2,156
+4% +$186K 1.19% 29
2023
Q1
$4.31M Buy
53,428
+6,405
+14% +$522K 1.09% 36
2022
Q4
$3.65M Buy
47,023
+8,758
+23% +$710K 0.94% 38
2022
Q3
$3.09M Buy
38,265
+1,888
+5% +$170K 0.86% 51
2022
Q2
$3.27M Buy
36,377
+2,201
+6% +$223K 0.91% 44
2022
Q1
$3.79M Buy
34,176
+1,954
+6% +$206K 0.84% 54
2021
Q4
$3.33M Buy
32,222
+2,059
+7% +$238K 0.71% 60
2021
Q3
$3.78M Buy
30,163
+620
+2% +$80.2K 0.89% 50
2021
Q2
$3.88M Buy
29,543
+1,179
+4% +$148K 0.89% 50
2021
Q1
$3.35M Buy
28,364
+497
+2% +$58.2K 0.83% 55
2020
Q4
$3.26M Buy
+27,867
New +$3.07M 0.91% 49

Other funds holding MDT

Kesler Norman & Wride's MDT Position: Q2 2026 in Review

Kesler Norman & Wride reduced its Medtronic (MDT) stake by 0.46% in Q2 2026, selling an estimated $5.41K and leaving 14,375 shares worth $1.12M. The position accounts for 0.18% of the portfolio, ranked #133.

Kesler Norman & Wride first reported a position in MDT in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.31M in Q3 2024. 627 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kesler Norman & Wride held 14,375 shares of Medtronic worth $1.12M as of Q2 2026.
  • Kesler Norman & Wride sold 67 Medtronic shares in Q2 2026, an estimated $5.41K.
  • Medtronic made up 0.18% of Kesler Norman & Wride's portfolio in Q2 2026, its #133 holding.
  • Kesler Norman & Wride first reported a position in Medtronic in Q4 2020 and has held it in 23 quarters since.
  • Kesler Norman & Wride's Medtronic position peaked at $5.31M in Q3 2024.
  • 627 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.